Follow the JW중외제약 stock price and the full directors' dealings record of the company, a listed equity based in South Korea. Shares are listed on KR KR, under the authority of DART (FSS). Operating in the Health Care sector, JW중외제약 has recorded 37 insider filings. Market capitalisation: €624.7bn. The latest transaction was filed on 11 March 2026 (Other). Among the most active insiders: JW홀딩스. The full history is accessible without an account.
37
Insider Decl.
0
Thresholds
·
12 ops.
Buy Volume
·
0 ops.
Sell Volume
22Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 1,024 of 26,182 companies
80.5
score / 100
Value
87
Quality
74
FCF yld11%
Earn yld11%
EV/EBITDA5.5x
ROE20%
Gross mgn46%
Net mgn7.9%
Debt/EBITDA0.5x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.